PDX Portal

Model Details

Patient Information for Model: HCI-011

Model Contact

Model: HCI-011
Model Contact: Alana Welm
Institution: HCI Breast PDX Program
Email: Alana.Welm@hci.utah.edu

Patient Information

Clinical Timeline

Color Keys:

Positive

Negative

N/A

Clinical Information at Collection

Clinical Biomarkers/Mutations at Collection

Pathology Information at Collection

Model Information for Model: HCI-011

Model Details - Initial Implantation of Patient Tissue

Biomarkers & Mutations

Model Details - Acceptable Conditions for Passaging

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

Histology Information for Model: HCI-011

There are no histology images for this model.

Metastasis Information for Model: HCI-011

Patient

PDX

Abdomen

Adrenal gland

Bone

Bones

Brain

CTC

Chest

Chest wall

Contralateral Breast

Dura

Fallopian Tubes

Head

Kidney

Liver

Lung

Lymph node

Lymph nodes

Neck

Ovary

Pancreas

Pericardium

Peritoneal cavity

Peritoneum

Pleura

Pleural effusion

Shoulder

Skin

Spine

Spleen

Thoracic Spine

Thymus

Patient Treatment Information for Model: HCI-011

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response
9	Doxorubicin, Cyclophosphamide, Pacitaxel	Neoadjuvant	57.67	58.08	150 days	Progressive disease
11	Radiation Therapy to supraclavicular nodes with axilla, chest wall and scar	Neoadjuvant	58.16	58.25	33 days	Progressive disease
13	Arimidex	Neoadjuvant	58.33	59.83	548 days	Progressive disease
15	Capcitabine	Neoadjuvant	59.41	59.83	153 days	Progressive disease